A total of 172 patients were recruited, of whom 7 were excluded due to refusal to perform tests, 1 was excluded due to hepatic steatosis associated with alpha-1-antitrypsin deficiency and 1 was excluded due to evidence of drug-induced hepatitis after liver biopsy. The gene discussed is SERPINA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.